For the quarter ending 2026-03-31, MYSE had $28,119 increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net loss | -2,861,610 | 1,167,661 | -4,207,780 |
| Depreciation and amortization | 4,264 | 15,942 | 25,488 |
| Amortization of right-of-use asset | 12,231 | 11,830 | 21,760 |
| Stock-based compensation | 225,861 | 230,879 | 509,825 |
| Stock-based professional fees - rpm interactive | - | - | 0 |
| Stock-based professional fees | 163,766 | 104,864 | 20,757 |
| Gain on deconsolidation of variable interest entities | - | 2,875,892 | 0 |
| Gain on extinguishment of liabilities | - | 62,658 | - |
| Reversal of short-term investment interest income discount | 43,692 | - | - |
| Accounts receivable | - | -141 | 17 |
| Unrealized loss on equity securities | 1,194,000 | - | - |
| Prepaid expenses | 19,608 | 77,874 | 39,645 |
| Assets of discontinued operations | - | -446,670 | - |
| Accounts payable and accrued expenses | -2,000 | 324,968 | 168,699 |
| Contract liabilities | -4 | -4 | -25 |
| Foreign currency exchange loss | - | - | 0 |
| Liabilities of discontinued operations | - | -26,845 | - |
| Non-cash research and development expense | - | - | 0 |
| Operating lease liability | -11,723 | -11,322 | -14,496 |
| Net cash used in operating activities | -1,251,131 | -751,640 | -3,515,434 |
| Proceeds from sale of short-term investments | 2,437,334 | 1,955,425 | 4,430,372 |
| Purchase of short-term investments | 1,090,494 | 591,024 | 5,824,170 |
| Purchases of property and equipment | - | 0 | 4,475 |
| Decrease in cash from sale of rpm interactive | - | 14,026 | - |
| Increase in intangible assets - capitalization of internal-use software | - | 5,500 | 190,838 |
| Net cash (used in) provided by investing activities | 1,346,840 | 1,344,875 | -1,589,111 |
| Proceeds from sale of common stock, net | - | 0 | 4,532,000 |
| Payment of deferred offering costs | - | - | 206,528 |
| Proceeds from notes payable - discontinued operations | - | 0 | 40,000 |
| Proceeds from sale of subsidiary common stock | - | - | 0 |
| Proceeds from sale of pre-funded warrants | - | - | 0 |
| Payment of deferred offering costs | 67,590 | 78,645 | - |
| Net cash (used in) provided by financing activities | -67,590 | 127,883 | 4,365,472 |
| Net increase in cash and cash equivalents | 28,119 | 721,118 | -739,073 |
| Cash and cash equivalents - beginning of period | 749,030 | 457,626 | 1,196,699 |
| Cash and cash equivalents - end of period | 777,149 | 749,030 | 457,626 |
Myseum.AI, Inc. (MYSE)
Myseum.AI, Inc. (MYSE)